Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan T Ross

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
ACS Chemical Biology|March 20, 2018
A High Content Screen in Macrophages Identifies Small Molecule Modulators of STING-IRF3 and NFkB SignalingPeter D Koch, Howard R Miller, Gary Yu, et al.
Elife|December 15, 2015
Ternatin and improved synthetic variants kill cancer cells by targeting the elongation factor-1A ternary complexJordan D Carelli, Steven G Sethofer, Geoffrey A Smith, et al.
Nature Chemical Biology|June 4, 2013
Identification of small molecules for human hepatocyte expansion and iPS differentiationJing Shan, Robert E Schwartz, Nathan T Ross, et al.
ACS Medicinal Chemistry Letters|December 21, 2012
A Potent and Selective Quinoxalinone-Based STK33 Inhibitor Does Not Show Synthetic Lethality in KRAS-Dependent CellsMichel Weïwer, James Spoonamore, Jingqiang Wei, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2012
STK33 kinase inhibitor BRD-8899 has no effect on KRAS-dependent cancer cell viabilityTuoping Luo, Kristina Masson, Jacob D Jaffe, et al.
The Journal of Clinical Investigation|March 13, 2012
A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer diseaseRashid Deane, Itender Singh, Abhay P Sagare, et al.
Angewandte Chemie (International Ed. in English)|July 17, 2015
Nannocystin A: an Elongation Factor 1 Inhibitor from Myxobacteria with Differential Anti-Cancer PropertiesPhilipp Krastel, Silvio Roggo, Markus Schirle, et al.
Journal of the American Chemical Society|November 12, 2010
An aldol-based build/couple/pair strategy for the synthesis of medium- and large-sized rings: discovery of macrocyclic histone deacetylase inhibitorsLisa A Marcaurelle, Eamon Comer, Sivaraman Dandapani, et al.
Cell Chemical Biology|April 1, 2021
CYP27A1-dependent anti-melanoma activity of limonoid natural products targets mitochondrial metabolismHyelim Cho, Qiong Shen, Lydia H Zhang, et al.
Nature Chemical Biology|October 12, 2023
Activation of human STING by a molecular glue-like compoundJie Li, Stephen M Canham, Hua Wu, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
ACS Chemical Biology|March 20, 2018
A High Content Screen in Macrophages Identifies Small Molecule Modulators of STING-IRF3 and NFkB SignalingPeter D Koch, Howard R Miller, Gary Yu, et al.
Elife|December 15, 2015
Ternatin and improved synthetic variants kill cancer cells by targeting the elongation factor-1A ternary complexJordan D Carelli, Steven G Sethofer, Geoffrey A Smith, et al.
Nature Chemical Biology|June 4, 2013
Identification of small molecules for human hepatocyte expansion and iPS differentiationJing Shan, Robert E Schwartz, Nathan T Ross, et al.
ACS Medicinal Chemistry Letters|December 21, 2012
A Potent and Selective Quinoxalinone-Based STK33 Inhibitor Does Not Show Synthetic Lethality in KRAS-Dependent CellsMichel Weïwer, James Spoonamore, Jingqiang Wei, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2012
STK33 kinase inhibitor BRD-8899 has no effect on KRAS-dependent cancer cell viabilityTuoping Luo, Kristina Masson, Jacob D Jaffe, et al.
The Journal of Clinical Investigation|March 13, 2012
A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer diseaseRashid Deane, Itender Singh, Abhay P Sagare, et al.
Angewandte Chemie (International Ed. in English)|July 17, 2015
Nannocystin A: an Elongation Factor 1 Inhibitor from Myxobacteria with Differential Anti-Cancer PropertiesPhilipp Krastel, Silvio Roggo, Markus Schirle, et al.
Journal of the American Chemical Society|November 12, 2010
An aldol-based build/couple/pair strategy for the synthesis of medium- and large-sized rings: discovery of macrocyclic histone deacetylase inhibitorsLisa A Marcaurelle, Eamon Comer, Sivaraman Dandapani, et al.
Cell Chemical Biology|April 1, 2021
CYP27A1-dependent anti-melanoma activity of limonoid natural products targets mitochondrial metabolismHyelim Cho, Qiong Shen, Lydia H Zhang, et al.
Nature Chemical Biology|October 12, 2023
Activation of human STING by a molecular glue-like compoundJie Li, Stephen M Canham, Hua Wu, et al.
Pageof 3